Tyrosyl-DNA Phosphodiesterase 1 Targeting for Modulation of Camptothecin-Based Treatment

E-ISSN： 1875-533x|17|15|1500-1508

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.15, 2010-05, pp. : 1500-1508

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors

By Huang Shar-yin N Pommier Yves Marchand Christophe

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 9, 2011-09 ,pp. : 1285-1292

Informa Healthcare

Access to resources Recommend Favorite

Camptothecin-based strategies for malignant disease

Inpharma, Vol. 1, Iss. 1394, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Targeting DNA Topoisomerase I with Non-Camptothecin Poisons

Current Medicinal Chemistry, Vol. 19, Iss. 8, 2012-03 ,pp. : 1238-1257

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor Physiology and Charge Dynamics of Anticancer Drugs: Implications for Camptothecin-based Drug Development

Current Medicinal Chemistry, Vol. 18, Iss. 9, 2011-03 ,pp. : 1367-1372

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies Targeting DNA Topoisomerase I in Cancer Chemotherapy: Camptothecins, Nanocarriers for Camptothecins, Organic Non-Camptothecin Compounds and Metal Complexes

Current Drug Targets, Vol. 17, Iss. 16, 2016-12 ,pp. : 1928-1939

Bentham Science Publishers

Access to resources Recommend Favorite